ClinicalTrials.gg
CompletedNCT06578338INFERUpdated Feb 4, 2026

Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children

An observational study in Growth; Stunting, Nutritional, sponsored by Danone Asia Pacific Holdings Pte, Ltd.. Completed at 1 site in Singapore. Open to participants aged 24 Months to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Danone Asia Pacific Holdings Pte, Ltd. (part of Danone) · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
250
Ages
24 Months to 6 Years
Sex
All
01

Study summary

An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's height using images taken by a healthcare professional or parents.

Read the detailed description

This is an exploratory, observation, data-collection study that aims to evaluate the performance of a Height Artificial Intelligence (HAI) algorithm in a real world setting. Images will be collected by parents or healthcare professionals, together with physical height measurements. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of using the algorithm will be collected for improvements.

02

Conditions studied

  • Growth; Stunting, Nutritional

Browse trials for

Keywords

  • Growth
  • Height
  • Artificial Intelligence
  • Algorithm
03

In context

Growth Disorders

227 studies on the registry are indexed under Growth Disorders; 25 are open to participants now.

This study's enrollment of 250 is close to the median of 231 across 78 observational studies indexed under Growth Disorders.

Browse Growth Disorders studies →

Lead sponsor

Danone Asia Pacific Holdings Pte, Ltd. is the lead sponsor of 29 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Months to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children aged above 24 months old and below 6 years of age with no physical deformities

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged above 24 months old and below 6 years old.
  • Parent(s) should have access to the internet and a smartphone or table to complete study questionnaires, take images and upload images.
  • Parent(s) should be able to comprehend the content of the study and complete the study questionnaires in English.
  • Written consent from parents and/or legally acceptable representative

Exclusion criteria

Exclusion Criteria:

  • Children who are unable to stand upright against a wall
  • Children who are unable to cooperate with standing height measurement
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
250 participants (actual)
Patient registry
No

Groups and cohorts

  • Children aged above 24 months old and below 6 years of age

    Children aged above 24 months old and below 6 years of age with no structural abnormalities of the lower limbs or orthopaedic conditions

    Other: Physical height measurement

Interventions

  • OtherPhysical height measurement

    Physical height will be measured and images will be collected for AI to estimate the height

06

What researchers measure

Primary outcomes

  1. Accuracy of the height AI (cm)

    Accuracy of the Height AI (cm) in a clinic and in a home setting, derived from: 1. The height AI prediction from images collected 2. The physical height measurements of subjects using WHO standard height measurement

    Time frame: 2 days

Secondary outcomes

  1. Accuracy of the Weight AI (kg)

    Accuracy of the Weight AI (kg) in a clinic and in a home setting, derived from: 1. The weight prediction from the standing images collected in this study 2. The WHO standard weight measurement of subjects

    Time frame: 2 days

Other outcomes

  1. Assessments by the parent on usability of the AI in a home-setting via study questionnaire

    1. Ease of collecting images (very easy to very difficult) 2. Acceptable range of height \& weight difference between AI prediction \& WHO measurement (between ≤1cm and \>5cm) 3. Frequency of measuring child's height \& weight at home (never,\< 1/month, at least \<1/month, at least 1 per 2 weeks,at least 1/week,\> 1/week,daily) 4. Usefulness of using digital tool to measure child's height \& weight at home (Very useful to Not very useful) 5. Frequency of using digital tool to measure child's height \& weight at home (never,\<1/month, at least 1/month, at least 1 per 2 weeks,at least 1/week,\>1/week,daily) 6. Likelihood and reason of using a digital tool to measure child's height \& weight at home (Very Likely to Very unlikely) 7. Sharing the child's height \& weight measured using digital tool with others (Very Likely to Very unlikely) 8. Use of mobile apps to track child's height \& weight (free text) 9. Other features/tools useful to measure child's height \& weight (free text)

    Time frame: 2 days

  2. Assessments by the investigator on usability of the AI in a clinic-setting via a questionnaire

    1. Acceptable range of height and weight difference between the height and weight AI from the WHO measurement (≤ 1cm, ≤ 2cm, ≤ 3cm, ≤ 4cm, ≤5cm, \>5cm) 2. Likelihood of using a digital tool to measure a child's height and weight in a clinical setting (Very Likely, Likely, Neutral, Unlikely, Very unlikely) 3. Likelihood of recommending parents to use a digital tool to measure their child's height and weight in a clinical setting (Very Likely, Likely, Neutral, Unlikely, Very unlikely) 4. Other features/tools they find useful to measure the child's height and weight (free text)

    Time frame: 2 days

  3. Assessments by the investigator on ease of collecting images in a clinic-setting via a questionnaire

    Investigator's assessment on the ease of collecting the images \[Very Easy, Easy, Normal, Difficult, Very Difficult\]

    Time frame: 2 days

07

Study locations

1 site
  • KK Women's and Children's Hospital
    Singapore, Singapore
08

References and documents

Publications

  • Yap F, Lee YS, Aw MMH. Growth Assessment and Monitoring during Childhood. Ann Acad Med Singap. 2018 Apr;47(4):149-155. PubMed 29777245 ↗
  • Schmidhuber J. Deep learning in neural networks: an overview. Neural Netw. 2015 Jan;61:85-117. doi: 10.1016/j.neunet.2014.09.003. Epub 2014 Oct 13. PubMed 25462637 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2024 to primary completion in Mar 2025, 5 months.

Of 23 industry-sponsored observational studies under Growth Disorders, half reached primary completion within 45 months of starting (the median); a quarter within 30 and three quarters within 55. This study's 5 months is below that.

Counting every sponsor, half of 42 studies reached it within 43 months; a quarter within 21 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2024
First posted
Aug 29, 2024
StartActual
Sep 9, 2024
Primary completionActual
Mar 4, 2025
CompletionActual
Mar 4, 2025
Last update
Feb 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06578338
Responsible party
Sponsor
First posted
Aug 29, 2024
Start date
Sep 9, 2024
Primary completion
Mar 4, 2025
Completion
Mar 4, 2025
Last update
Feb 4, 2026

Study contacts

Fabian Yap, MBBS
principal investigator · KK Women's and Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion